N6-(2,2-diphenylethyl)adenosine, a novel adenosine receptor agonist with antipsychotic-like activity.
D000241:Adenosine / Q000031:analogs & derivatives* / Q000494:pharmacology; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D001259:Ataxia / Q000139:chemically induced; D001362:Avoidance Learning / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D006220:Haloperidol / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D051381:Rats; D011983:Receptors, Purinergic / Q000378:metabolism*; D013329:Structure-Activity Relationship; D013881:Thioridazine / Q000494:pharmacology
D014150:Antipsychotic Agents; D011983:Receptors, Purinergic; C047235:N-(1-methyl-2-phenylethyl)adenosine; C053810:N(6)-(2,2-diphenylethyl)adenosine; D006220:Haloperidol; D000241:Adenosine; D013881:Thioridazine